Figure 6
Figure 6. The proliferation and apoptosis of Tfh cells in HCs and WAS patients or WT and WAS KO mice. (A) Flow cytometry analysis of caspase-3 or Ki-67 staining of Tfh cells in HCs and WAS patients stimulated without or with PHA. (B) The percentage of Ki-67+ Tfh cells in PBMCs from HCs and WAS patients stimulated with PHA. (C) The percentage of Ki-67+ Tfh cells in the spleen of WT and WAS KO mice stimulated with PHA. The percentage of caspase-3+ Tfh cells in PBMCs from HCs and WAS patients stimulated with PHA (D) or without PHA (E). The percentage of caspase-3+ Tfh cells in the spleen of WT and WAS KO mice stimulated with PHA (F) or without PHA (G).

The proliferation and apoptosis of Tfh cells in HCs and WAS patients or WT and WAS KO mice. (A) Flow cytometry analysis of caspase-3 or Ki-67 staining of Tfh cells in HCs and WAS patients stimulated without or with PHA. (B) The percentage of Ki-67+ Tfh cells in PBMCs from HCs and WAS patients stimulated with PHA. (C) The percentage of Ki-67+ Tfh cells in the spleen of WT and WAS KO mice stimulated with PHA. The percentage of caspase-3+ Tfh cells in PBMCs from HCs and WAS patients stimulated with PHA (D) or without PHA (E). The percentage of caspase-3+ Tfh cells in the spleen of WT and WAS KO mice stimulated with PHA (F) or without PHA (G).

Close Modal

or Create an Account

Close Modal
Close Modal